Cargando…

Transcriptomic pathway analysis of urokinase receptor silenced breast cancer cells: a microarray study

Urokinase plasminogen activator receptor (PLAUR) has been implicated in a variety of physiological and pathological conditions. The multi-functionality of PLAUR is due to its capacity to interact with many co-receptors to regulate extracellular proteolysis and intracellular signaling. Recent reports...

Descripción completa

Detalles Bibliográficos
Autores principales:	Narayanaswamy, Pavan B., Baral, Tapan K., Haller, Hermann, Dumler, Inna, Acharya, Kshitish, Kiyan, Yulia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731897/ https://www.ncbi.nlm.nih.gov/pubmed/29254187 http://dx.doi.org/10.18632/oncotarget.21351

Ejemplares similares

Loss of Urokinase Receptor Sensitizes Cells to DNA Damage and Delays DNA Repair
por: Narayanaswamy, Pavan B., et al.
Publicado: (2014)

CHK1 and RAD51 activation after DNA damage is regulated via urokinase receptor/TLR4 signaling
por: Narayanaswamy, Pavan B, et al.
Publicado: (2016)

Urokinase Receptor Counteracts Vascular Smooth Muscle Cell Functional Changes Induced by Surface Topography
por: Kiyan, Yulia, et al.
Publicado: (2013)

TLR4 Response to LPS Is Reinforced by Urokinase Receptor
por: Kiyan, Yulia, et al.
Publicado: (2020)

oxLDL inhibits differentiation and functional activity of osteoclasts via scavenger receptor-A mediated autophagy and cathepsin K secretion
por: Dawodu, Damilola, et al.
Publicado: (2018)

Stat1 Nuclear Translocation by Nucleolin upon Monocyte Differentiation
por: Jerke, Uwe, et al.
Publicado: (2009)

The Urokinase/Urokinase Receptor System in Mast Cells: Effects of its Functional Interaction with fMLF Receptors
por: Rossi, Francesca Wanda, et al.
Publicado: (2016)

Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor
por: Zhu, Ran, et al.
Publicado: (2022)

Heparanase-2 protects from LPS-mediated endothelial injury by inhibiting TLR4 signalling
por: Kiyan, Yulia, et al.
Publicado: (2019)

Author Correction: Heparanase-2 protects from LPS-mediated endothelial injury by inhibiting TLR4 signalling
por: Kiyan, Yulia, et al.
Publicado: (2021)

Urokinase, urokinase receptor, and plasminogen activator inhibitor-1 expression on podocytes in immunoglobulin A glomerulonephritis
por: Lee, Ji-Hye, et al.
Publicado: (2014)

TIPMaP: a web server to establish transcript isoform profiles from reliable microarray probes
por: Chitturi, Neelima, et al.
Publicado: (2013)

Role of Urokinase Receptor in Tumor Progression and Development
por: Noh, Hyangsoon, et al.
Publicado: (2013)

Urokinase receptor and resistance to targeted anticancer agents
por: Gonias, Steven L., et al.
Publicado: (2015)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
por: Kouhpayeh, Shirin, et al.
Publicado: (2017)

Calcium dobesilate reduces SARS-CoV-2 entry into endothelial cells by inhibiting virus binding to heparan sulfate
por: Kiyan, Yulia, et al.
Publicado: (2022)

Author Correction: Calcium dobesilate reduces SARS-CoV-2 entry into endothelial cells by inhibiting virus binding to heparan sulfate
por: Kiyan, Yulia, et al.
Publicado: (2023)

The Contribution of the Urokinase Plasminogen Activator and the Urokinase Receptor to Pleural and Parenchymal Lung Injury and Repair: A Narrative Review
por: Tucker, Torry A., et al.
Publicado: (2021)

Urokinase-Type Plasminogen Activator Receptor Regulates Prosurvival and Angiogenic Properties of Cardiac Mesenchymal Stromal Cells
por: Dergilev, Konstantin, et al.
Publicado: (2023)

Binding of urokinase to specific receptor sites on human breast cancer membranes.
por: Needham, G. K., et al.
Publicado: (1987)

Upregulation of urokinase receptor expression on migrating endothelial cells
Publicado: (1993)

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors
Publicado: (1987)

Involvement of the Soluble Urokinase Receptor in Chondrosarcoma Cell Mobilization
por: Bifulco, Katia, et al.
Publicado: (2011)

Soluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus
por: Dande, Ranadheer R., et al.
Publicado: (2017)

Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer
por: Masucci, Maria Teresa, et al.
Publicado: (2022)

Soluble Urokinase Receptor and Mortality in Kidney Transplant Recipients
por: Morath, Christian, et al.
Publicado: (2022)

Dual Inhibition of Classical Protein Kinase C-α and Protein Kinase C-β Isoforms Protects Against Experimental Murine Diabetic Nephropathy
por: Menne, Jan, et al.
Publicado: (2013)

Semi-quantitation of urokinase plasminogen activator and its receptor in breast carcinomas by immunocytochemistry.
por: Kennedy, S., et al.
Publicado: (1998)

The Urokinase Receptor (uPAR) Facilitates Clearance of Borrelia burgdorferi
por: Hovius, Joppe W. R., et al.
Publicado: (2009)

Urokinase-type plasminogen activator receptor in IgA nephropathy
por: Ahn, Shin-Young, et al.
Publicado: (2014)

Urokinase plasminogen activator receptor polymorphisms and airway remodelling in asthma
por: Ierodiakonou, Despo, et al.
Publicado: (2016)

Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas
por: Carriero, Maria Vincenza, et al.
Publicado: (2017)

The Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. Therapeutic Implications
por: Li Santi, Anna, et al.
Publicado: (2021)

Soluble Urokinase Receptor Levels Are Correlated with Focal Segmental Glomerulosclerosis Lesions in IgA Nephropathy: A Cohort Study from China
por: Guo, Shui-Ming, et al.
Publicado: (2015)

Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma.
por: Cantero, D., et al.
Publicado: (1997)

A Role for Caveolin and the Urokinase Receptor in Integrin-mediated Adhesion and Signaling
por: Wei, Ying, et al.
Publicado: (1999)

The Receptor for Urokinase Regulates TLR2 Mediated Inflammatory Responses in Neutrophils
por: Liu, Gang, et al.
Publicado: (2011)

Soluble Urokinase Plasminogen Activator Receptor as a Marker for Use of Antidepressants
por: Haastrup, Eva, et al.
Publicado: (2014)

Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
por: Godtfredsen, Nina S., et al.
Publicado: (2018)

Soluble urokinase plasminogen activator receptor for the prediction of ventilator-associated pneumonia
por: van Oort, Pouline M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dvq1hb9nrgg9i2jacjk7nrmun8